​

Autonomix Medical Stock (NASDAQ:AMIX)

RevenueOwnershipFinancialsChart
Autonomix Medical by TradingView

Previous Close

$0.58

52W Range

$0.53 - $4.14

50D Avg

$0.89

200D Avg

$1.34

Market Cap

$2.76M

Avg Vol (3M)

$5.53M

Beta

-2.86

Div Yield

-

AMIX Company Profile

Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.

Show More

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

5

IPO Date

Jan 29, 2024

Website

AMIX Performance

AMIX Financial Summary

Mar 24Mar 23Mar 22
Revenue---
Operating Income$-7.47M$-1.99M$-13.59M
Net Income$-15.43M$-1.99M$-13.33M
EBITDA$-15.27M-$752.45K
Basic EPS$-21.10$-0.11$-0.71
Diluted EPS$-21.09$-0.11$-0.71

Fiscal year ends in Mar 24 | Currency in USD

Peer Comparison

TickerCompany
VEROVenus Concept Inc.
KALAKALA BIO, Inc.
NAOVNanoVibronix, Inc.
BBLGBone Biologics Corporation
FLGCFlora Growth Corp.
MOVEMovano Inc.
DHAIDIH Holding US, Inc.
HSCSHeartSciences Inc.